About Evid Science

Evid Science utilizes artificial intelligence to analyze the entirety of primary medical literature, creating a comprehensive database of therapy evidence for healthcare decision-making. This approach addresses the challenge of accessing reliable and up-to-date medical evidence, enabling life sciences companies to optimize their research and market access strategies.

<problem> Life sciences companies face challenges in efficiently accessing and synthesizing the growing volume of primary medical literature to inform healthcare decision-making. Traditional methods of literature review are time-consuming and may not capture the entirety of available evidence, potentially leading to suboptimal research and market access strategies. </problem> <solution> Genesis Research Group provides tech-enabled solutions for real-world evidence (RWE), health economics and outcomes research (HEOR), and market access, leveraging stakeholder insights and a flexible engagement model. The company's integrated approach encompasses evidence strategy, generation, optimization, and communication, supported by technology platforms and expert teams. Genesis Research Group helps life sciences companies optimize insights and evidence for regulatory, provider, and payer requirements. </solution> <features> - Data-agnostic real-world evidence (RWE) expertise utilizing global datasets - Health economics and outcomes research (HEOR) services for evidence planning, generation, and communication - Market access and pricing solutions, including rapid payer insights and HTA support - Stakeholder insights platform to secure payer and KOL feedback across the product lifecycle - Technology-assisted evidence synthesis using the EVID AI platform - Flexible Integrated Team (FIT) engagement model providing tailored, cross-functional teams - Rapid Payer Response (RPR) platform for agile market access strategy development - Interactive RWE dashboards and evidence management platforms </features> <target_audience> The primary target audience includes life sciences companies seeking to enhance their evidence generation, value demonstration, and market access strategies. </target_audience>

What does Evid Science do?

Where is Evid Science located?

Evid Science is based in El Segundo, United States.

When was Evid Science founded?

Evid Science was founded in 2017.

Location

El Segundo, United States

Founded

2017

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Evid Science

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

evidscience.com

Founded 2017 – El Segundo, United States

Funding

No funding information available.

Team

No team information available.

Company Description

Problem

Life sciences companies face challenges in efficiently accessing and synthesizing the growing volume of primary medical literature to inform healthcare decision-making. Traditional methods of literature review are time-consuming and may not capture the entirety of available evidence, potentially leading to suboptimal research and market access strategies.

Solution

Genesis Research Group provides tech-enabled solutions for real-world evidence (RWE), health economics and outcomes research (HEOR), and market access, leveraging stakeholder insights and a flexible engagement model. The company's integrated approach encompasses evidence strategy, generation, optimization, and communication, supported by technology platforms and expert teams. Genesis Research Group helps life sciences companies optimize insights and evidence for regulatory, provider, and payer requirements.

Features

Data-agnostic real-world evidence (RWE) expertise utilizing global datasets

Health economics and outcomes research (HEOR) services for evidence planning, generation, and communication

Market access and pricing solutions, including rapid payer insights and HTA support

Stakeholder insights platform to secure payer and KOL feedback across the product lifecycle

Technology-assisted evidence synthesis using the EVID AI platform

Flexible Integrated Team (FIT) engagement model providing tailored, cross-functional teams

Rapid Payer Response (RPR) platform for agile market access strategy development

Interactive RWE dashboards and evidence management platforms

Target Audience

The primary target audience includes life sciences companies seeking to enhance their evidence generation, value demonstration, and market access strategies.